03:06 AM EDT, 07/28/2026 (MT Newswires) -- Allergy Therapeutics (AGY.L) appointed Chief Strategy Officer Helge Weiner-Trapness as executive chairman to succeed Peter Jensen. The British biotechnology company said Tuesday that Jensen will remain in the company as a nonexecutive director to ensure an orderly handover of responsibilities.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.